OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ‘entourage effect’ or ‘hodge-podge hashish’: the questionable rebranding, marketing, and expectations of cannabis polypharmacy
Peter S. Cogan
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 8, pp. 835-845
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
Andrea M. Tomko, Erin G. Whynot, Lee Ellis, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1985-1985
Open Access | Times Cited: 177

The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects
Ahmad K. Al-Khazaleh, Xian Zhou, Deep Jyoti Bhuyan, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 410-410
Open Access | Times Cited: 28

Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity
Justin LaVigne, Ryan Hecksel, Attila Keresztes, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 90

Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
Jonathan Vela, Lene Dreyer, Kristian Kjær Petersen, et al.
Pain (2021) Vol. 163, Iss. 6, pp. 1206-1214
Open Access | Times Cited: 80

Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics
Anne Katrin Schlag, Saoirse E. O’Sullivan, Rayyan Zafar, et al.
Neuropharmacology (2021) Vol. 191, pp. 108586-108586
Closed Access | Times Cited: 64

Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Catalina Christensen, Martin Rose, Claus Cornett, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 28

Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis
Tory R. Spindle, C. Austin Zamarripa, Ethan B. Russo, et al.
Drug and Alcohol Dependence (2024) Vol. 257, pp. 111267-111267
Closed Access | Times Cited: 12

Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1

Analgesic Potential of Terpenes Derived fromCannabis sativa
Erika Liktor‐Busa, Attila Keresztes, Justin LaVigne, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1269-1297
Open Access | Times Cited: 48

Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
Janet Hardy, Ristan M. Greer, Georgie Huggett, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 7, pp. 1444-1452
Closed Access | Times Cited: 37

Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products
Erin C. Berthold, Shyam H. Kamble, Raju S. Kanumuri, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 4, pp. 427-435
Closed Access | Times Cited: 17

Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science
Osvaldo Marinotti, Miles Sarill
Journal of Dietary Supplements (2020) Vol. 17, Iss. 5, pp. 517-526
Closed Access | Times Cited: 40

Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ9‐Tetrahydrocannabinol Without Improving Its Analgesic Properties
Andriy A. Gorbenko, Jules A. A. C. Heuberger, Linda E. Klumpers, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 5, pp. 1289-1303
Open Access | Times Cited: 5

Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation
Noa Raz, Aharon M. Eyal, Dana Berneman Zeitouni, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115548-115548
Open Access | Times Cited: 12

Topical Use of Cannabis sativa L. Biochemicals
Léonid Mnekin, Lionel Ripoll
Cosmetics (2021) Vol. 8, Iss. 3, pp. 85-85
Open Access | Times Cited: 26

Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy
Francisco T. Chacon, Wesley M. Raup‐Konsavage, Kent E. Vrana, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3142-3142
Open Access | Times Cited: 18

Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review
João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 5, pp. 1202-1216
Closed Access | Times Cited: 10

Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Edward Chesney, Philip McGuire, Tom P. Freeman, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 26

The impact of extraction protocol on the chemical profile of cannabis extracts from a single cultivar
Janina K. Bowen, Jacqueline M. Chaparro, Alexander M. McCorkle, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 18

Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
João Luís Q. Simei, José Diogo R. Souza, João Francisco Cordeiro Pedrazzi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1644-1644
Open Access | Times Cited: 2

Biosynthesis of Nature-Inspired Unnatural Cannabinoids
Kevin Lim, Yan Ping Lim, Yossa Dwi Hartono, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2914-2914
Open Access | Times Cited: 14

Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease
Michael G. Morash, Jessica Nixon, Lori M. N. Shimoda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7

An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
Simon Erridge, Ophilia Leung, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 4, pp. 616-632
Open Access | Times Cited: 4

Cannabidiol in anxiety disorders: Current and future perspectives
João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, et al.
International review of neurobiology (2024), pp. 205-234
Closed Access | Times Cited: 1

Public health considerations about tetrahydrocannabinol‐infused beverages
Cassidy R. LoParco, Kayla K. Tillett, Julia Chen‐Sankey, et al.
Addiction (2024)
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top